October 2024

Precise Health

Ecosystem /

Precise Health is a biotech startup aiming to revolutionize the treatment of bacterial infections by replacing broad-spectrum antibiotics with personalized bacteriophage technology – starting with inflammatory skin conditions.

Precise Health platform’s leverages the specificity and selectivity of bacteriophages, microorganisms able to target and eliminate harmful bacteria while preserving the beneficial microbiota hence significantly reducing the likelihood of developing antimicrobial resistance.

Precise Health Read More »

Logo Carré_Ninsun biotech sans le nom 2026 06 03

Ninsun Biotech

Monthey Resident /

Ninsun Biotech is developing the missing biomarker for immunotherapy decision-making in Non Small Cell Lung Cancer.
While immunotherapy is dramatically improving survival, yet up to 80% of patients fail to respond.
By specifically detecting Cancer Stem Cells directly in tumor tissue through a standard IHC test, NinStem Lung™ aims to identify patients unlikely to respond to immunotherapy, improving outcomes while reducing unnecessary toxicity and healthcare costs.
Entering clinical development toward CE IVDR, NinStem Lung™ is designed to complement PD-L1 testing and help clinicians in their decision to treat.
The company targets a market of more than 400,000 tests annually across Europe and the US.
We predict the right treatment at the right time.

Ninsun Biotech Read More »

Start typing and press enter to search

Scroll to Top